BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36863097)

  • 1. Macrophage inflammatory protein-1β as a novel therapeutic target for renal protection in diabetic kidney disease.
    Chang TT; Li SY; Lin LY; Chen C; Chen JW
    Biomed Pharmacother; 2023 May; 161():114450. PubMed ID: 36863097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
    Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
    Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPN14 deficiency alleviates podocyte injury through suppressing inflammation and fibrosis by targeting TRIP6 in diabetic nephropathy.
    Lin Y; Shao Z; Zhao M; Li J; Xu X
    Biochem Biophys Res Commun; 2021 Apr; 550():62-69. PubMed ID: 33684622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum amyloid A and inflammation in diabetic kidney disease and podocytes.
    Anderberg RJ; Meek RL; Hudkins KL; Cooney SK; Alpers CE; Leboeuf RC; Tuttle KR
    Lab Invest; 2015 Mar; 95(3):250-62. PubMed ID: 25531567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
    Zuo F; Wang Y; Xu X; Ding R; Tang W; Sun Y; Wang X; Zhang Y; Wu J; Xie Y; Liu M; Wang Z; Yi F
    Metabolism; 2024 Jan; 150():155724. PubMed ID: 37952690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding proteins tristetraprolin and human antigen R are novel modulators of podocyte injury in diabetic kidney disease.
    Guo J; Lei M; Cheng F; Liu Y; Zhou M; Zheng W; Zhou Y; Gong R; Liu Z
    Cell Death Dis; 2020 Jun; 11(6):413. PubMed ID: 32487989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
    Jin J; Ye M; Hu K; Gong J; He Q
    Histol Histopathol; 2019 Jun; 34(6):671-682. PubMed ID: 30475382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klotho-derived peptide 6 ameliorates diabetic kidney disease by targeting Wnt/β-catenin signaling.
    Chen X; Tan H; Xu J; Tian Y; Yuan Q; Zuo Y; Chen Q; Hong X; Fu H; Hou FF; Zhou L; Liu Y
    Kidney Int; 2022 Sep; 102(3):506-520. PubMed ID: 35644285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy.
    Wei TT; Yang LT; Guo F; Tao SB; Cheng L; Huang RS; Ma L; Fu P
    Acta Pharmacol Sin; 2021 Feb; 42(2):252-263. PubMed ID: 32948825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of Histone Deacetylase 6 Ameliorates Podocyte Injury in Diabetic Kidney Disease in Mice].
    Hou Q; Kan S; Zhang M; Xu F; Liu Z; Jiang S
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1097-1104. PubMed ID: 38162083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
    Wang H; Feng Z; Xie J; Wen F; Jv M; Liang T; Li J; Wang Y; Zuo Y; Li S; Li R; Li Z; Zhang B; Liang X; Liu S; Shi W; Wang W
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1096-F1107. PubMed ID: 29361670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
    Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
    Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Hu-lu-ba-wan protects diabetic glomerular podocytes via promoting PKM2-mediated mitochondrial dynamic homeostasis.
    Gong M; Guo Y; Dong H; Wu F; He Q; Gong J; Lu F
    Phytomedicine; 2024 Jan; 123():155247. PubMed ID: 38128393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated expression but redundant function of the long non-coding RNA HOTAIR in diabetic kidney disease.
    Majumder S; Hadden MJ; Thieme K; Batchu SN; Niveditha D; Chowdhury S; Yerra VG; Advani SL; Bowskill BB; Liu Y; Vakili H; Alghamdi TA; White KE; Geldenhuys L; Siddiqi FS; Advani A
    Diabetologia; 2019 Nov; 62(11):2129-2142. PubMed ID: 31399844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGC-1α ameliorates kidney fibrosis in mice with diabetic kidney disease through an antioxidative mechanism.
    Zhang L; Liu J; Zhou F; Wang W; Chen N
    Mol Med Rep; 2018 Mar; 17(3):4490-4498. PubMed ID: 29344670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte derived TNF-α mediates monocyte differentiation and contributes to glomerular injury.
    Nishad R; Mukhi D; Kethavath S; Raviraj S; Paturi ASV; Motrapu M; Kurukuti S; Pasupulati AK
    FASEB J; 2022 Dec; 36(12):e22622. PubMed ID: 36421039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin ameliorates renal fibrosis by upregulating CPT1α-mediated fatty acid oxidation in diabetic kidney disease.
    Hu H; Li W; Hao Y; Peng Z; Zou Z; Liang W
    Phytomedicine; 2024 Jan; 122():155162. PubMed ID: 37922789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rutaecarpine protects podocytes in diabetic kidney disease by targeting VEGFR2/NLRP3-mediated pyroptosis.
    Hu X; Wang J; Jiang L; Liu X; Ge Q; Wang Q; Qi X; Wu Y
    Int Immunopharmacol; 2024 Mar; 130():111790. PubMed ID: 38447417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice.
    Liu W; Chen X; Wang Y; Chen Y; Chen S; Gong W; Chen T; Sun L; Zheng C; Yin B; Li S; Luo C; Huang Q; Xiao J; Xu Z; Peng F; Long H
    Pharmacol Res; 2019 Dec; 150():104506. PubMed ID: 31669149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.